Tag:
danoprevir
Latest Headlines
Latest Headlines
Pirfenidone will make or break InterMune
Brisbane, CA-based InterMune ( ITMN ) has sold all rights to its promising hepatitis C drug danoprevir to Roche for $175 million in cash and dissolved the collaboration agreement they signed in 2006.
InterMune soars on promising hep C trial
InterMune has announced positive results from a mid-stage study of danoprevir, a potential treatment for hepatitis C. The news sent the company's shares to their highest in eight years, according to
